{"id":958841,"date":"2026-05-14T08:00:10","date_gmt":"2026-05-14T08:00:10","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/958841\/"},"modified":"2026-05-14T08:00:10","modified_gmt":"2026-05-14T08:00:10","slug":"heart-medication-recall-is-your-prescription-affected","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/958841\/","title":{"rendered":"Heart Medication Recall: Is Your Prescription Affected?"},"content":{"rendered":"

Recent research<\/a> highlighted that a commonly over-consumed ingredient in many American diets is salt. It would be an oversimplification to say this is why nearly half of Americans are managing high blood pressure, as the CDC notes<\/a>, but there is almost certainly some correlation between our collective sodium intake and the rising concern around high blood pressure.<\/p>\n

If you\u2019re one of the estimated 15 million Americans on metoprolol\u2014which data suggest<\/a> is the sixth most-prescribed drug with a reported 59.5 million prescriptions dispensed in 2023\u2014you\u2019ll want to know about the latest recall on heart and blood pressure medication that was distributed nationwide.<\/p>\n

On May 12, the U.S. Food and Drug Administration (FDA) issued a report<\/a> revealing a quantity of 17,304 bottles of Metoprolol Succinate Extended-Release Tablets, USP, 25 milligrams (mg), were voluntarily recalled from the market by the distributor, New Jersey-based Ascend Laboratories. As is common for supply chain origin, the drug was manufactured in India, by Alkem Laboratories.<\/p>\n

The FDA listed \u201cfailed dissolution failure\u201d as the reason for the recall, which was initiated April 27. Whether this means the extended-release formulation wasn\u2019t efficacious isn\u2019t specified.<\/p>\n

The FDA report states the recall affects lot number 25140859 with a January 2027 expiration date.<\/p>\n

The Mayo Clinic<\/a>, which lists<\/a> Metoprolol as a beta blocker, explains: \u201cBeta blockers cause the heart to beat more slowly and with less force. This lowers blood pressure. Beta blockers also help widen veins and arteries to improve blood flow.\u201d Mayo experts add that beta blockers may be indicated for heart failure, chest pain, arrhythmia<\/a>, migraine headaches, and some types of tremors.<\/p>\n

This happens to be the second blood pressure and heart medication announced in an FDA enforcement report this week, following an event for a significantly smaller number of Enalapril Maleate tablets<\/a>.<\/p>\n

Get The Healthy <\/b>newsletter<\/a> and follow The Healthy<\/b> on Facebook<\/a> and Instagram<\/a>. Keep reading:<\/p>\n

\t\t